‘Post Trials’ data, ICMR needs to revise Covid-19 drug regimen’
‘Post Trials’ data, ICMR needs to revise Covid-19 drug regimen’
IndiaTimes
0 shares
1 views
You might like
Related news coverage
Post trials’ data, need to revise treatment regimen for Covid-19: Experts
Results of the global `Solidarity Trial’ which declared the widely-prescribed anti-viral drug, Remdesivir ineffective for saving..
IndiaTimes